Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophagus Squamous Cell Carcinoma (SCC)”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Early research (Phase 1)Study completedNCT01351103
What this trial is testing

LGK974 in Patients With Malignancies Dependent on Wnt Ligands

Who this might be right for
Pancreatic CancerBRAF Mutant Colorectal CancerMelanoma+5 more
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Study completedNCT03712397
What this trial is testing

Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy

Who this might be right for
Head & Neck Cancer
National Health Research Institutes, Taiwan 59
Testing effectiveness (Phase 2)Ended earlyNCT02213133
What this trial is testing

Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas

Who this might be right for
Squamous Cell Carcinoma
Karyopharm Therapeutics Inc 45
Testing effectiveness (Phase 2)WithdrawnNCT04625543
What this trial is testing

Neoadjuvant Immunotherapy to ESCC

Who this might be right for
Esophagus SCC
Qilu Hospital of Shandong University
Testing effectiveness (Phase 2)UnknownNCT03585673
What this trial is testing

Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal Carcinoma

Who this might be right for
Esophagus Squamous Cell Carcinoma (SCC)Metastatic Cancer
Sung Yong Oh 38
Not applicableStudy completedNCT04090554
What this trial is testing

Cytosponge™ Feasibility Study in Tanzania

Who this might be right for
Esophageal DiseasesEsophagus SCC
International Agency for Research on Cancer 101
Early research (Phase 1)Study completedNCT04925284
What this trial is testing

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Who this might be right for
Non Small Cell Lung CancerCervical CancerSCCHN+8 more
Exelixis 269
Not applicableActive Not RecruitingNCT07074535
What this trial is testing

CT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Cancer (SCC)Recurrent Laryngeal Nerve PalsyDeep Learning+1 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 500
Not applicableLooking for participantsNCT05591053
What this trial is testing

Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans

Who this might be right for
Esophagus CancerEsophageal CancerEsophageal Neoplasms+7 more
Activ Surgical 70
Early research (Phase 1)Looking for participantsNCT06242470
What this trial is testing

MGC026 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerMetastatic Cancer+19 more
MacroGenics 250
Early research (Phase 1)Ended earlyNCT03114319
What this trial is testing

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC)KRAS G12-mutant NSCLCEsophageal Squamous Cell Cancer (SCC)+4 more
Novartis Pharmaceuticals 227
Early research (Phase 1)Ended earlyNCT04000529
What this trial is testing

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies

Who this might be right for
Non-small Cell Lung CarcinomaHead and Neck Squamous Cell CarcinomaEsophageal SCC+2 more
Novartis Pharmaceuticals 122
Testing effectiveness (Phase 2)Study completedNCT03339843
What this trial is testing

Multiorgan Metabolic Imaging Response Assessment of Abemaciclib

Who this might be right for
Esophageal AdenocarcinomaEsophagus SCCCholangiocarcinoma+2 more
Jules Bordet Institute 85